Policy Advisory Board

Key stakeholders with experience in translating research to policy will be integrated and connected through our activities. These stakeholders include integrated healthcare system providers and payers, substance use disorder and health care providers, public and private payers, federal and state policy makers, and the pharmaceutical industry. The Policy Advisory Board represent the perspectives of these stakeholders and will be instrumental in the functioning and operations of the Dissemination and Policy Core. Members of the Policy Advisory Board assist in disseminating policy-relevant findings to key stakeholders.


Mady Chalk, PhD, MSW

Principal and Managing Director Formerly Director of the Center on Policy Research and Analysis at the Treatment Research Institute (TRI)
The Chalk Group

Robert Forman, PhD

Director of Professional Relations and Policy
Alkermes, Inc.

Michael Horberg, MD

Executive Director of Research and Community Benefit of the Mid-Atlantic Permanente Medical Group Director of the Mid-Atlantic Permanente Research Institute (MAPRI) Director of HIV/AIDS for Kaiser Permanente
Kaiser Permanente

Thomas McLellan, PhD

Co-founder of Treatment Research Institute Former Science Advisor and Deputy Director of the White House Office of National Drug Control Policy (ONDCP)
Treatment Research Institute

Edmondo J. Robinson, MD, MBA, FACP

Physician-in-chief at Christiana Care’s Wilmington Hospital
Christiana Care’s Wilmington Hospital

Joshua Sharfstein, MD

Associate Dean of Public Health Practice, Johns Hopkins Bloomberg School of Public Health Former Secretary of the Maryland Department of Health and Mental Hygiene Former Principal Deputy Commissioner of the U.S Food and Drug Administration
Johns Hopkins Bloomberg School of Public Health

Hyong Un, MD

Chief Psychiatric Officer for Aetna’s Behavioral Health